Company Info
| Year Established: | 2022 |
| Ticker: | MRK |
| Exchange: | NYSE |
Contacts
| Primary: | Ranjit Bindra, MD, PhD Co-Founder & CEO |
| Other: | Joseph Park, PharmD VP, Corporate Development & Clinical Affairs |
Company Description
Modifi Bio, a Merck company, is redefining the rules of oncology treatment: eradicating cancer via direct DNA modification.
